Tag: Alzheimer’s

Higher risk for cognitive decline, vascular dementia, Alzheimer disease seen with high blood glucose

Association seen for larger volumes of white matter hyperintensities with disease severity, but not vascular risk, in bvFTD

Among Framingham Heart Study participants, one in five cases were severe

Decline in language function, but not episodic memory, seen for primary progressive aphasia associated with Alzheimer disease

After six to 12 months of treatment with the drug, patients no longer had amyloid protein plaques

Higher prevalence of depression, need for assistance with activities of daily living seen for high proportion of residents with dementia

Adverse financial events seen years before diagnosis and become more prevalent after diagnosis

Test from C2N Diagnostics is meant for people 60 years and older who have cognitive issues and are being assessed for Alzheimer disease

Rate of progression from MCI to AD increased with ApoE4, anxiety, lower hippocampal and entorhinal cortex volumes

Association seen in older women persisted even at PM_2.5 levels below U.S. regulatory standards